If you've been through the diagnostic process for POTS or dysautonomia, you probably had a tilt table test. You lay flat, got tilted upright while monitors tracked your heart rate and blood pressure, and at some point someone said, "Positive tilt table test. You have POTS."
That test answered one question: does your heart rate rise too much when you stand up? It didn't answer the much more important one, which is why. Autonomic testing is how that question gets worked on, and this page covers what each test measures and what our team adds.
What Is Autonomic Testing?
Autonomic testing uses standardized tests of the nerves that control heart rate, blood pressure and sweating, such as the Valsalva maneuver, deep breathing, a sweat test and a tilt test (Novak, 2024). In POTS, testing confirms the diagnosis, excludes other causes of orthostatic intolerance and can sort POTS into subtypes (Goodman, 2018).
What Does the Tilt Table Test Tell You?
In someone with frequent symptoms on standing for at least 3 months, a sustained heart rate rise of 30 beats per minute or more within 10 minutes of standing or head-up tilt, without orthostatic hypotension, meets the POTS heart rate criterion. Ages 12 to 19 need a rise of 40 or more (Vernino, 2021).
That validates your symptoms and puts a name on the pattern, but it tells you nothing about mechanism. It's the equivalent of confirming that your car won't start without looking under the hood. The heart rate rule is also blunt. In 15 POTS patients and 15 healthy controls, it flagged 93% of patients on a 10-minute tilt and 60% of the controls (Plash, 2013). And how you rate your symptoms doesn't reliably predict what testing finds. In 2,627 patients, symptom questionnaire scores didn't correlate with test grades (Novak, 2024).
POTS is a hemodynamic pattern that can be produced by several different underlying mechanisms, and the treatment that works depends on which one is driving your case. The Canadian Cardiovascular Society calls it "a heterogeneous syndrome with likely several underlying pathophysiological processes, and not a specific disease" (Raj, 2020). In most people our team sees, what looks like an overactive sympathetic system is the body compensating for too little blood flow to the brain, and deconditioning usually follows POTS.
Which Autonomic Tests Are Included, and What Does Each Measure?
The international consensus groups autonomic tests by what they read: sympathetic cardiovascular adrenergic function, parasympathetic cardiovagal function and sudomotor function (Cheshire, 2021).
| Test | What it reads |
|---|---|
| Tilt or active stand | Heart rate and blood pressure on standing or on head-up tilt (Benarroch, 2012). A tilt produced a larger heart rate rise than an active stand at every 5-minute interval from 5 to 30 minutes (Plash, 2013). |
| Deep breathing | Heart rate variability while you breathe deeply, a measure of cardiovagal (parasympathetic) function (Shields, 2009) |
| QSART (sweat test) | Sweat nerve (sudomotor) function, the most widely used sudomotor test (Buchmann, 2019) |
| Skin biopsy | Nerve fiber density in a skin sample from the lower leg, used to diagnose small fiber neuropathy (Lauria, 2010). Among people with POTS who get tested, roughly a quarter to a half show signs of it (Zhang, 2022; Haensch, 2014). |
Standard testing: deep breathing reads cardiovagal function, QSART reads sweat nerve function and a tilt or stand reads heart rate and blood pressure, and the scores are read together. Brain blood flow isn't one of the scored measures. A 2025 review notes that rises in heart rate or drops in blood pressure get used as proxies for it because flow is hard to measure (Khan, 2025).
What our team adds: transcranial Doppler and end-tidal CO2 ask whether the heart rate rise is protecting falling brain blood flow. A related study found that upright flow velocity and end-tidal CO2 predicted lightheadedness in 22 patients with orthostatic intolerance, while heart rate and blood pressure didn't (Coelho, 2024).
What Does Our Team Add to Standard Testing?
The standard scores don't include a measure of brain blood flow (Cheshire, 2021). A 2025 review says heart rate and blood pressure are used as proxies for it because "CBF is not easy to measure," and that in ME/CFS and long COVID they're "frequently normal despite significant drops in CBF" (Khan, 2025). In a tilt study of 429 people with ME/CFS, 82% of the 247 whose heart rate and blood pressure responses were normal still showed an abnormal drop in blood flow through the neck arteries (van Campen, 2020).
Cerebral Blood Flow Regulation
With transcranial Doppler, our team measures blood flow velocity to the brain in real time (Norcliffe-Kaufmann, 2018). This answers a critical question: is the tachycardia a response to inadequate cerebral blood flow, or is cerebral blood flow being maintained despite the heart rate increase? In our team's view, the heart rate rise in POTS compensates for brain blood flow. POTS is that compensation succeeding, and orthostatic hypotension is the compensation failing. Studies of brain blood flow in POTS don't all agree. Flow velocity fell before breathing sped up in a breathless subset of patients (Del Pozzi, 2014), and another study found cerebral autoregulation similar to controls in many patients (Schondorf, 2005).
Our team often leaves the transcranial Doppler on after the tilt. The patient sits and turns the head, and our team watches whether a held position changes flow velocity in the middle cerebral artery.
Vestibular-Autonomic Interaction
The vestibular system connects directly to autonomic control centers in the brainstem. When vestibular processing is inaccurate, it can generate inappropriate autonomic responses, including tachycardia, blood pressure fluctuations and nausea. A 2022 review says orthostatic dizziness may be in part related to an impaired vestibulo-sympathetic reflex, in the setting of orthostatic hypotension (Bogle, 2022). Our team checks eye movements at the bedside, and in 15 POTS patients on a 60 degree head-up tilt, the patients showed fewer, slower and smaller saccades than the 15 healthy controls (Rodriguez, 2025).
Cerebellar Autonomic Calibration
The cerebellum calibrates autonomic responses. It fine-tunes how much your blood vessels constrict when you stand, how quickly your heart rate adjusts and how smoothly the transition occurs. When it's dysfunctional, those responses can be imprecise, delayed or overshooting. Our team assesses it through oculomotor testing, including saccade accuracy, pursuit quality and VOR calibration, along with coordination tasks.
Cervical Contribution
The cervical spine houses the vertebral arteries and proprioceptive pathways that influence autonomic function. Cervical dysfunction can affect blood flow and alter proprioceptive input to vestibular and autonomic centers, which produces symptoms that overlap significantly with POTS. Our team tests what happens to blood flow and proprioception during actual neck movement, which static imaging misses.
What Did Testing Show in 2 Patients?
In the video, the first patient had a seated Doppler on day 2 or 3 of treatment. With her head neutral, the right middle cerebral artery read a mean velocity of 38 cm/s. In head flexion it fell to 28 cm/s, which our team called "over like a 26% drop." At the retest, both sides read 50 cm/s with the head neutral. In flexion the right side "just dropped a couple centimeters per second," and she reported a little discomfort. She could stand up right after the test, which wasn't possible on the first day.
The second patient's tilt at her initial exam showed flow below the clinic's targets on both sides the whole time. The targets are at least 90% of the flat reading in the first minute and at least 85% after. After 7 full days of treatment she held flow through the whole test, and she said it was easy to get up off the table. These are 2 patients, so the video shows what testing finds in a person and can't show that treatment works for others.
How Does Testing Change the Treatment Conversation?
If salt and fluids worked for you, the standard approach did its job. Our team sees extra testing as a fit for people who haven't responded, whose symptoms are worsening, or who have dizziness, visual or thinking symptoms. When testing points to brain blood flow, treatment goes there. When it points to vestibular, cerebellar or cervical contributions, treatment goes there instead, and many patients have more than one.
Our team doesn't dismiss the usual medications. Beta blockers lower the heart rate. In a video answering a viewer's question about metoprolol, our team said that can ease palpitations and a sense of anxiety "because those are a function of the high heart rate." In our team's view, the ceiling is that it "doesn't necessarily solve the problem that the heart rate was trying to solve."
Autonomic Testing: FAQ
Is POTS an autonomic disorder?
POTS is a chronic disorder of the autonomic nervous system (Vernino, 2021), and autonomic testing is part of its evaluation (Goodman, 2018). The Canadian Cardiovascular Society describes it as a heterogeneous syndrome with likely several underlying processes (Raj, 2020).
Is there a test for dysautonomia?
Autonomic testing is a panel of tests read together, because no single test is enough to grade the problem (Cheshire, 2021). A history and physical exam add to the panel (Goodman, 2018), and our team does bedside neurological checks, described in the dysautonomia bedside exam.
What is the test for POTS?
A tilt table test or active stand that shows a sustained heart rate rise of 30 beats per minute or more within 10 minutes (40 or more at ages 12 to 19), without orthostatic hypotension, in someone with symptoms on standing, meets the heart rate criterion for POTS (Vernino, 2021).
Can a QSART test diagnose POTS?
A QSART can't diagnose POTS, because POTS is defined by a sustained heart rate rise on standing or tilt, with symptoms and without orthostatic hypotension (Vernino, 2021). A QSART tests sweat nerve function and is the most widely used sudomotor test (Buchmann, 2019). A skin biopsy counts nerve fibers to assess small fiber neuropathy, which is a separate question (Lauria, 2010).
Wondering what's driving your symptoms? The free Roadmap walks through how our team finds it and where to start.
Get the free RoadmapSources
- Novak P, Systrom DM, Marciano SP, et al. Mismatch between subjective and objective dysautonomia. Scientific Reports. 2024;14(1):2513. doi:10.1038/s41598-024-52368-x
- Cheshire WP, Freeman R, Gibbons CH, et al. Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clinical Neurophysiology. 2021;132(2):666-682. doi:10.1016/j.clinph.2020.11.024
- Goodman BP. Evaluation of postural tachycardia syndrome (POTS). Autonomic Neuroscience. 2018;215:12-19. doi:10.1016/j.autneu.2018.04.004
- Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Canadian Journal of Cardiology. 2020;36(3):357-372. doi:10.1016/j.cjca.2019.12.024
- Benarroch EE. Postural Tachycardia Syndrome: A Heterogeneous and Multifactorial Disorder. Mayo Clinic Proceedings. 2012;87(12):1214-1225. doi:10.1016/j.mayocp.2012.08.013
- Plash WB, Diedrich A, Biaggioni I, et al. Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics. Clinical Science. 2013;124(2):109-114. doi:10.1042/CS20120276
- Shields RW. Heart rate variability with deep breathing as a clinical test of cardiovagal function. Cleveland Clinic Journal of Medicine. 2009;76(4 suppl 2):S37-S40. doi:10.3949/ccjm.76.s2.08
- Buchmann SJ, Penzlin AI, Kubasch ML, et al. Assessment of sudomotor function. Clinical Autonomic Research. 2019;29(1):41-53. doi:10.1007/s10286-018-0530-2
- Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. European Journal of Neurology. 2010;17(7):903-912. doi:10.1111/j.1468-1331.2010.03023.x
- Zhang R, Mayuga K, Shields R, et al. Skin biopsy and quantitative sudomotor axon reflex testing in patients with postural orthostatic tachycardia syndrome. Cureus. 2022;14(11):e31021. doi:10.7759/cureus.31021
- Haensch CA, Tosch M, Katona I, et al. Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle & Nerve. 2014;50(6):956-961. doi:10.1002/mus.24245
- Khan MS, Miller AJ, Ejaz A, et al. Cerebral Blood Flow in Orthostatic Intolerance. Journal of the American Heart Association. 2025;14(3):e036752. doi:10.1161/JAHA.124.036752
- Coelho FMS, de Carvalho Cremaschi RM, Novak P. Cerebral blood flow and end-tidal CO2 predict lightheadedness during head-up tilt in patients with orthostatic intolerance. Neurological Sciences. 2024;45(12):5771-5778. doi:10.1007/s10072-024-07673-8
- Del Pozzi AT, Schwartz CE, Tewari D, et al. Reduced Cerebral Blood Flow With Orthostasis Precedes Hypocapnic Hyperpnea, Sympathetic Activation, and Postural Tachycardia Syndrome. Hypertension. 2014;63(6):1302-1308. doi:10.1161/HYPERTENSIONAHA.113.02824
- Schondorf R, Benoit J, Stein R. Cerebral autoregulation is preserved in postural tachycardia syndrome. Journal of Applied Physiology. 2005;99(3):828-835. doi:10.1152/japplphysiol.00225.2005
- Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Autonomic Neuroscience. 2021;235:102828. doi:10.1016/j.autneu.2021.102828
- van Campen CLMC, Verheugt FWA, Rowe PC, et al. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clinical Neurophysiology Practice. 2020;5:50-58. doi:10.1016/j.cnp.2020.01.003
- Norcliffe-Kaufmann L, Galindo-Mendez B, Garcia-Guarniz AL, et al. Transcranial Doppler in autonomic testing: standards and clinical applications. Clinical Autonomic Research. 2018;28(2):187-202. doi:10.1007/s10286-017-0454-2
- Rodriguez B, Pantano L, Nef T, et al. Visual symptoms in postural tachycardia syndrome: An investigation of position-dependent visual exploration. European Journal of Neurology. 2025;32(1):e16507. doi:10.1111/ene.16507
- Bogle JM, Benarroch E, Sandroni P. Vestibular-autonomic interactions: beyond orthostatic dizziness. Current Opinion in Neurology. 2022;35(1):126-134. doi:10.1097/WCO.0000000000001013
Get Your POTS & Dysautonomia Roadmap
A free guide to understanding what's actually happening in your brain, and what to do about it.
Get the Free Roadmap